Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia (Q36967029)

From Wikidata

Jump to navigation Jump to search

scientific article published on 04 September 2015

Language	Label	Description	Also known as
English	Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia	scientific article published on 04 September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia (English)

1 reference

Europe PubMed Central

17 August 2017

Hagop Kantarjian

12

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

17 August 2017

Gautam Borthakur

9

object named as

Gautam Borthakur

1 reference

Europe PubMed Central

17 August 2017

Guillermo Garcia-Manero

11

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

17 August 2017

Naveen Pemmaraju

10

object named as

Naveen Pemmaraju

1 reference

Europe PubMed Central

17 August 2017

Stefan O Ciurea

24

object named as

Stefan O Ciurea

1 reference

Europe PubMed Central

17 August 2017

Richard E Champlin

23

object named as

Richard E Champlin

1 reference

Europe PubMed Central

17 August 2017

Partow Kebriaei

17

object named as

Partow Kebriaei

1 reference

Europe PubMed Central

17 August 2017

Carlos B Bueso-Ramos

8

object named as

Carlos Bueso-Ramos

1 reference

Europe PubMed Central

17 August 2017

Elizabeth J Shpall

22

object named as

Elizabeth J Shpall

1 reference

Europe PubMed Central

17 August 2017

19

object named as

Betul Oran

1 reference

Europe PubMed Central

17 August 2017

2

object named as

Uday Popat

1 reference

Europe PubMed Central

17 August 2017

7

object named as

Julianne Chen

1 reference

Europe PubMed Central

17 August 2017

14

object named as

Chitra Hosing

1 reference

Europe PubMed Central

17 August 2017

Gabriela Rondon

6

object named as

Gabriela Rondon

1 reference

Europe PubMed Central

17 August 2017

4

object named as

Sameh Gaballa

1 reference

Europe PubMed Central

17 August 2017

13

object named as

Amin Alousi

1 reference

Europe PubMed Central

17 August 2017

Piyanuch Kongtim

1

object named as

Piyanuch Kongtim

1 reference

Europe PubMed Central

17 August 2017

Katayoun Rezvani

20

object named as

Katayoun Rezvani

1 reference

Europe PubMed Central

17 August 2017

16

object named as

Issa F Khouri

1 reference

Europe PubMed Central

17 August 2017

5

object named as

Riad El Fakih

1 reference

Europe PubMed Central

17 August 2017

author name string

Antonio Jimenez

3

1 reference

Europe PubMed Central

17 August 2017

Paolo Anderlini

15

1 reference

Europe PubMed Central

17 August 2017

Borje S Andersson

18

1 reference

Europe PubMed Central

17 August 2017

David Marin

21

1 reference

Europe PubMed Central

17 August 2017

publication date

4 September 2015

1 reference

Europe PubMed Central

17 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

17 August 2017

22

1 reference

Europe PubMed Central

17 August 2017

1

1 reference

Europe PubMed Central

17 August 2017

47-53

1 reference

Europe PubMed Central

17 August 2017

An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

29 September 2017

Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

27 June 2018

Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Treatment of chronic myelomonocytic leukemia with azacitidine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Activity of azacitidine in chronic myelomonocytic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892364

4 September 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelodysplastic syndromes: a scoring system with prognostic significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of allo-SCT for chronic myelomonocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myelomonocytic leukemia--clinicobiological characteristics: a multivariate analysis in a series of 70 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26343946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2015.08.031

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36967029&oldid=1857503682"